365 related articles for article (PubMed ID: 16731836)
1. Functional effects of mutations at F35 in the NH2-terminus of Kir6.2 (KCNJ11), causing neonatal diabetes, and response to sulfonylurea therapy.
Proks P; Girard C; Baevre H; Njølstad PR; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1731-7. PubMed ID: 16731836
[TBL] [Abstract][Full Text] [Related]
2. Mutations at the same residue (R50) of Kir6.2 (KCNJ11) that cause neonatal diabetes produce different functional effects.
Shimomura K; Girard CA; Proks P; Nazim J; Lippiat JD; Cerutti F; Lorini R; Ellard S; Hattersley AT; Barbetti F; Ashcroft FM
Diabetes; 2006 Jun; 55(6):1705-12. PubMed ID: 16731833
[TBL] [Abstract][Full Text] [Related]
3. A novel mutation causing DEND syndrome: a treatable channelopathy of pancreas and brain.
Shimomura K; Hörster F; de Wet H; Flanagan SE; Ellard S; Hattersley AT; Wolf NI; Ashcroft F; Ebinger F
Neurology; 2007 Sep; 69(13):1342-9. PubMed ID: 17652641
[TBL] [Abstract][Full Text] [Related]
4. Diabetes and hypoglycaemia in young children and mutations in the Kir6.2 subunit of the potassium channel: therapeutic consequences.
Flechtner I; de Lonlay P; Polak M
Diabetes Metab; 2006 Dec; 32(6):569-80. PubMed ID: 17296510
[TBL] [Abstract][Full Text] [Related]
5. Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes.
Gloyn AL; Pearson ER; Antcliff JF; Proks P; Bruining GJ; Slingerland AS; Howard N; Srinivasan S; Silva JM; Molnes J; Edghill EL; Frayling TM; Temple IK; Mackay D; Shield JP; Sumnik Z; van Rhijn A; Wales JK; Clark P; Gorman S; Aisenberg J; Ellard S; Njølstad PR; Ashcroft FM; Hattersley AT
N Engl J Med; 2004 Apr; 350(18):1838-49. PubMed ID: 15115830
[TBL] [Abstract][Full Text] [Related]
6. Iptakalim, a vascular ATP-sensitive potassium (KATP) channel opener, closes rat pancreatic beta-cell KATP channels and increases insulin release.
Misaki N; Mao X; Lin YF; Suga S; Li GH; Liu Q; Chang Y; Wang H; Wakui M; Wu J
J Pharmacol Exp Ther; 2007 Aug; 322(2):871-8. PubMed ID: 17522344
[TBL] [Abstract][Full Text] [Related]
7. Successful sulfonylurea treatment of a neonate with neonatal diabetes mellitus due to a new KCNJ11 mutation.
Ješić MM; Ješić MD; Maglajlić S; Sajić S; Necić S
Diabetes Res Clin Pract; 2011 Jan; 91(1):e1-3. PubMed ID: 21056492
[TBL] [Abstract][Full Text] [Related]
8. Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features.
Proks P; Antcliff JF; Lippiat J; Gloyn AL; Hattersley AT; Ashcroft FM
Proc Natl Acad Sci U S A; 2004 Dec; 101(50):17539-44. PubMed ID: 15583126
[TBL] [Abstract][Full Text] [Related]
9. Functional analysis of six Kir6.2 (KCNJ11) mutations causing neonatal diabetes.
Girard CA; Shimomura K; Proks P; Absalom N; Castano L; Perez de Nanclares G; Ashcroft FM
Pflugers Arch; 2006 Dec; 453(3):323-32. PubMed ID: 17021801
[TBL] [Abstract][Full Text] [Related]
10. Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11.
Mlynarski W; Tarasov AI; Gach A; Girard CA; Pietrzak I; Zubcevic L; Kusmierek J; Klupa T; Malecki MT; Ashcroft FM
Nat Clin Pract Neurol; 2007 Nov; 3(11):640-5. PubMed ID: 17982434
[TBL] [Abstract][Full Text] [Related]
11. Kir6.2 mutations associated with neonatal diabetes reduce expression of ATP-sensitive K+ channels: implications in disease mechanism and sulfonylurea therapy.
Lin CW; Lin YW; Yan FF; Casey J; Kochhar M; Pratt EB; Shyng SL
Diabetes; 2006 Jun; 55(6):1738-46. PubMed ID: 16731837
[TBL] [Abstract][Full Text] [Related]
12. Outpatient transition of an infant with permanent neonatal diabetes due to a KCNJ11 activating mutation from subcutaneous insulin to oral glyburide.
Bremer AA; Ranadive S; Lustig RH
Pediatr Diabetes; 2008 Jun; 9(3 Pt 1):236-9. PubMed ID: 18221420
[TBL] [Abstract][Full Text] [Related]
13. A Kir6.2 mutation causing severe functional effects in vitro produces neonatal diabetes without the expected neurological complications.
Tammaro P; Flanagan SE; Zadek B; Srinivasan S; Woodhead H; Hameed S; Klimes I; Hattersley AT; Ellard S; Ashcroft FM
Diabetologia; 2008 May; 51(5):802-10. PubMed ID: 18335204
[TBL] [Abstract][Full Text] [Related]
14. Functional analysis of two Kir6.2 (KCNJ11) mutations, K170T and E322K, causing neonatal diabetes.
Tarasov AI; Girard CA; Larkin B; Tammaro P; Flanagan SE; Ellard S; Ashcroft FM
Diabetes Obes Metab; 2007 Nov; 9 Suppl 2():46-55. PubMed ID: 17919178
[TBL] [Abstract][Full Text] [Related]
15. Functional effects of naturally occurring KCNJ11 mutations causing neonatal diabetes on cloned cardiac KATP channels.
Tammaro P; Proks P; Ashcroft FM
J Physiol; 2006 Feb; 571(Pt 1):3-14. PubMed ID: 16339180
[TBL] [Abstract][Full Text] [Related]
16. Kir6.2 mutations causing neonatal diabetes provide new insights into Kir6.2-SUR1 interactions.
Tammaro P; Girard C; Molnes J; Njølstad PR; Ashcroft FM
EMBO J; 2005 Jul; 24(13):2318-30. PubMed ID: 15962003
[TBL] [Abstract][Full Text] [Related]
17. Neonatal diabetes caused by a homozygous KCNJ11 mutation demonstrates that tiny changes in ATP sensitivity markedly affect diabetes risk.
Vedovato N; Cliff E; Proks P; Poovazhagi V; Flanagan SE; Ellard S; Hattersley AT; Ashcroft FM
Diabetologia; 2016 Jul; 59(7):1430-1436. PubMed ID: 27118464
[TBL] [Abstract][Full Text] [Related]
18. Mutations of the same conserved glutamate residue in NBD2 of the sulfonylurea receptor 1 subunit of the KATP channel can result in either hyperinsulinism or neonatal diabetes.
Männikkö R; Flanagan SE; Sim X; Segal D; Hussain K; Ellard S; Hattersley AT; Ashcroft FM
Diabetes; 2011 Jun; 60(6):1813-22. PubMed ID: 21617188
[TBL] [Abstract][Full Text] [Related]
19. Variable phenotypic spectrum of diabetes mellitus in a family carrying a novel KCNJ11 gene mutation.
D'Amato E; Tammaro P; Craig TJ; Tosi A; Giorgetti R; Lorini R; Ashcroft FM
Diabet Med; 2008 Jun; 25(6):651-6. PubMed ID: 18544102
[TBL] [Abstract][Full Text] [Related]
20. Transfer to sulphonylurea therapy in adult subjects with permanent neonatal diabetes due to KCNJ11-activating [corrected] mutations: evidence for improvement in insulin sensitivity.
Malecki MT; Skupien J; Klupa T; Wanic K; Mlynarski W; Gach A; Solecka I; Sieradzki J
Diabetes Care; 2007 Jan; 30(1):147-9. PubMed ID: 17192350
[No Abstract] [Full Text] [Related]
[Next] [New Search]
